Evidence map›Paper›PMID 41419744›Full record

ArticleScientific reports2025

Assessment of awareness level among women about cervical smears, human papillomavirus (HPV), and HPV vaccine in Saudi Arabia.

Arezki Azzi, Reham Al-Dhelaan, Abdullah Al-Fahd, Omar Almukhalafi, Nasser Al-Tayar, Abdullah Abutheeb, Majed Bahmid

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Arezki AzziDepartment of Biochemistry, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia. arazzi@gmail.com.
Reham Al-DhelaanDepartment of Biochemistry, College of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Abdullah Al-FahdCollege of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Omar AlmukhalafiCollege of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Nasser Al-TayarCollege of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Abdullah AbutheebCollege of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.
Majed BahmidCollege of Medicine, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, Saudi Arabia.

Funding

the Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU) IMSIU-DDRSP2501
6 · The paper itself

Abstract

There is relatively low awareness about Human papillomavirus (HPV) in Saudi Arabia. Increased awareness is required to gain better knowledge, particularly among the general population. This study aims to evaluate the awareness level of women about cervical smears, HPV, and HPV vaccine. Also, this study evaluates the effectiveness of the Saudi Ministry of Health's campaign aimed to raise awareness of HPV and the HPV vaccine by comparing data collected before and after the campaign. This study employed a cross-sectional, online survey-based design conducted in Saudi Arabia. Data were collected during two periods: 2022 and 2024. The target participants were women aged 18 and older residing in Saudi Arabia. Exclusions included individuals with a history of HPV infection and those who did not provide consent. The questionnaire comprised 26 items, organized into three sections: sociodemographic information, awareness levels of HPV and the HPV vaccine, and cervical screening practices and vaccine acceptance. A total of 858 women participated in this study. Overall, 49.4% of women were aware of HPV, and 38% were aware of the HPV vaccine. Over two-thirds (67.6%) were willing to receive a free HPV vaccination. Social media was the most common source of information (HPV: 63.2%; HPV vaccine: 57.1%). From 2022 to 2024, there was a significant increase in HPV awareness, rising from 38.8% in 2022 to 71.1% in 2024 (p < 0.001), and awareness of the HPV vaccine significantly increased from 28.2% to 58.7% (p < 0.001). Despite these improvements in awareness, only 25.8% of participants reported having undergone cervical cancer screening (Pap smear). The main drivers for awareness are knowledge-based (knowing the vaccine exists for men/children, knowing where to get it). For acceptance of HPV vaccine, the strongest psychological driver is a parent's willingness to vaccinate their children. This study highlights the success of the Saudi Ministry of Health's campaign in raising awareness about HPV and its vaccine. Despite this progress, the low uptake of cervical cancer screening remains a critical public health issue. Greater emphasis on the importance of pap smear tests is needed to enhance early detection and prevention of cervical cancer.

Indexed as

Health Knowledge, Attitudes, PracticePapillomavirus InfectionsPapillomavirus VaccinesUterine Cervical NeoplasmsVaginal SmearsAdolescentAdultCross-Sectional StudiesFemaleHuman Papillomavirus VirusesHumansMiddle AgedPapillomaviridaePatient Acceptance of Health CareSaudi ArabiaSurveys and QuestionnairesPapillomavirus VaccinesCervical cancerCervical smearHPV vaccineHPV vaccine acceptance driversHPV vaccine awareness predictorsHuman papillomavirusKnowledge-based factorsPapillomavirusPap smearVaccine hesitancy

Identifiers

PMID41419744
PMCPMC12717125

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.